Real-time enrollment status for this e1 ubiqutin-activating enzyme, x-linked, autoinflammatory, somatic syndrome clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 8:27 AM UTC
| NCT Number | NCT06538181 |
| Recruiting Status | Recruiting |
| Condition | E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic Syndrome |
| Phase | PHASE1 |
| Target Enrollment | 15 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Washington University School of Medicine |
| Last Updated on CT.gov | July 15, 2026 (Jul 15, 2026) |
As of August 29, 2026: Clinical trial NCT06538181 is currently recruiting participants. This phase1 study for e1 ubiqutin-activating enzyme, x-linked, autoinflammatory, somatic syndrome is actively seeking new participants at 1 location across the United States. The study is sponsored by Washington University School of Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06538181 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06538181 was last updated Jul 15, 2026 (July 15, 2026). HelloStudys verifies this status automatically.